共 114 条
From portable dialysis to a bioengineered kidney
被引:64
作者:
van Gelder, Maaike K.
[1
,2
]
Mihaila, Silvia M.
[1
,2
,3
]
Jansen, Jitske
[3
]
Wester, Maarten
[1
,2
]
Verhaar, Marianne C.
[1
,2
]
Joles, Jaap A.
[1
,2
]
Stamatialis, Dimitrios
[4
]
Masereeuw, Roos
[3
]
Gerritsen, Karin G. F.
[1
,2
]
机构:
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands
[2] Univ Utrecht, Regenerat Med Utrecht, Utrecht, Netherlands
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands
[4] Univ Twente, MIRA Inst Biomed Engn & Tech Med, Dept Biomat Sci & Technol, Bio Artificial Organs, Enschede, Netherlands
基金:
欧盟地平线“2020”;
关键词:
Bioartificial kidney;
wearable artificial kidney;
protein bound uremic toxins;
implantable artificial kidney;
renal replacement therapy;
FLOW PERITONEAL-DIALYSIS;
ACUTE-RENAL-FAILURE;
TUBULAR EPITHELIAL-CELLS;
IN-CENTER HEMODIALYSIS;
PROTEIN-BOUND TOXINS;
BIOARTIFICIAL KIDNEY;
UREMIC TOXINS;
MAINTENANCE HEMODIALYSIS;
HEMOFILTRATION MEMBRANES;
ARTIFICIAL-KIDNEY;
D O I:
10.1080/17434440.2018.1462697
中图分类号:
R318 [生物医学工程];
学科分类号:
0831 ;
摘要:
Introduction: Since the advent of peritoneal dialysis (PD) in the 1970s, the principles of dialysis have changed little. In the coming decades, several major breakthroughs are expected.Areas covered: Novel wearable and portable dialysis devices for both hemodialysis (HD) and PD are expected first. The HD devices could facilitate more frequent and longer dialysis outside of the hospital, while improving patient's mobility and autonomy. The PD devices could enhance blood purification and increase technique survival of PD. Further away from clinical application is the bioartificial kidney, containing renal cells. Initially, the bioartificial kidney could be applied for extracorporeal treatment, to partly replace renal tubular endocrine, metabolic, immunoregulatory and secretory functions. Subsequently, intracorporeal treatment may become possible.Expert commentary: Key factors for successful implementation of miniature dialysis devices are patient attitudes and cost-effectiveness. A well-functioning and safe extracorporeal blood circuit is required for HD. For PD, a double lumen PD catheter would optimize performance. Future research should focus on further miniaturization of the urea removal strategy. For the bio-artificial kidney (BAK), cost effectiveness should be determined and a general set of functional requirements should be defined for future studies. For intracorporeal application, water reabsorption will become a major challenge.
引用
收藏
页码:323 / 336
页数:14
相关论文